Congenital Malformation
11
2
2
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
Characterization and Contribution of Genome-wide DNA Methylation (DNA Methylation Episignatures) in Rare Diseases With Prenatal Onset
Evaluation of Rapid First-line Genome Sequencing for Prenatal Diagnosis of Congenital Malformations in Comparison With Chromosomal Microarray and Exome Sequencing
Genomic Sequencing and Personalized Treatment for Birth Defects in Neonatal Intensive Care Units
Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway
Pregnancy Environment and Newborn Malformations
Drinking Water PFAS, Pregnancy Outcome and Maternal Morbidity
eHealth as an Aid for Facilitating and Supporting Self-management in Families With Long-term Childhood Illness
A Population-based Study of Drug Exposures and Adverse Pregnancy Outcomes in China (DEEP)
The Pilot Study of High-throughput Sequencing in Neonatal Birth Defects
Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission
The Impact of the Birth of a Child With a Rare Abdomino-thoracic Malformation